Page 5 - Heart Failure Guidelines

Pediatric Heart Failure Guidelines

Chemotherapy Induced Cardiomyopathy ..................................................................................29
Additional Evaluation for Patient with Chemotherapy Induced Cardiomyopathy ....................29
Medical Management Chemotherapy Induced Cardiomyopathy ............................................29
Follow-up Schedule for Chemotherapy Induced Cardiomyopathy ..........................................29
Neuromuscular Disorder Associated Cardiomyopathy ..............................................................30

Additional Evaluation for Patient with Neuromuscular Disorder associated Cardiomyopathy .30
Introduction ...............................................................................................................................30
Initial Evaluation ........................................................................................................................30
Ongoing Management ...............................................................................................................30

Dose escalation plan (outpatient monitoring) .........................................................................31
Imaging .....................................................................................................................................32
Arrhythmia Screening ................................................................................................................32
Advanced Therapies .................................................................................................................32
Myocarditis ................................................................................................................................33
Additional Evaluation for possible Myocarditis .......................................................................33
Medical Management Myocarditis .........................................................................................33
Immunotherapy Management Myocarditis .............................................................................33
Follow-up Schedule for Myocarditis .......................................................................................34

Medication Doses .....................................................................................................................35
Anticoagulation Schedules ........................................................................................................37

Updated 12/4/2018 page 5